• Search Clinical Trials
• Patient Notification Service
• Overview of Clinical Trials
• Volunteering for a Trial
• Understanding Informed Consent
• Post Clinical Trials

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Immunology | Hematology
Disease Category: Non-Hodgkin's Lymphoma
Location: United States, CA

Trial Information

A Phase 2 Study of Brentuximab Vedotin in Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphoma (NHL)

This study is being done to test if brentuximab vedotin has an effect on cancer in subjects with non Hodgkin lymphoma. The side effects (unwanted effects) of brentuximab vedotin in subjects with non Hodgkin lymphoma will also be studied. It is not known if brentuximab vedotin is better or worse than other treatment you might be given.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.